Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. sea4pain

Sea4Pain SIGNED

Development of a novel analgesic for chronic pain from marine-derived compounds

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 Sea4Pain project word cloud

Explore the words cloud of the Sea4Pain project. It provides you a very rough idea of what is the project "Sea4Pain" about.

modulate    alternative    venture    breakthroughs    250    inflict    opioid    co    capital    biotechnological    professionals    expand    treatments    pharmaceutical    benefits    worth    class    marine    strategy    first    applies    health    shows    moderate    billion    demonstrated    noxious    brain    kv    raised    sensing    quality    2015    mode    life    differentiated    chronic    founded    analgesic    drive    world    fifth    portuguese    drugs    modulator    platform    4    suffer    give    market    action    525    compound    2013    sea4us    acting    addiction    lab    toxicity    series    huge    neurons    innovative    grants    patented    population    ease    supporting    pathologies    drug    ion    suffering    disruptive    2022    pain    roll    team    crowdfunding    derivate    biomedicine    adverse    severe    patients    constantly    extremely    51    derivatives    13    pharmaceuticals    habituation    efficacy    limited    sea4pain    switch    channels    discovery    cagr    compounds    alleviate    global    received    38    channel   

Project "Sea4Pain" data sheet

The following table provides information about the project.

Coordinator		 SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS LDA 

Organization address
address: RUA DO POENTE S/N
city: SAGRES
postcode: 8650 378
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Portugal [PT]
 Project website http://sea4us.pt/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS LDA PT (SAGRES) coordinator 50˙000.00

Map

 Project objective

'The Sea4Pain project will expand and define the development strategy for Sea4Us’s “Drug Discovery and Development Platform” – a platform that applies novel biotechnological approaches to exploit marine derived compounds for the development of novel pharmaceuticals highly relevant for biomedicine. The first lab-based research results have clearly demonstrated the benefits of marine compounds in a series of pathologies, like chronic pain, and the huge potential of its derivate products in the health market. In particular, our innovative breakthroughs will lead to the development of a unique, high efficacy analgesic (ion channel modulator), with reduced toxicity and limited side-effects (Sea4Pain). This extremely innovative approach shows a differentiated mode-of-action (acting directly in the 'pain switch'), that will give rise to a new class of pharmaceutical drugs with no expected adverse effects on the brain (currently being patented). The disruptive compound will modulate specific ion channels in pain-sensing neurons (Kv), for which there is no known modulator, and ease the suffering of one fifth of the World's population who constantly suffer from chronic pain. Sea4Pain will offer alternative treatments for patients suffering from moderate to severe chronic pain. Current drugs in the market (opioid derivatives and others) do alleviate pain but co-inflict important noxious effects (habituation, addiction, loss of drive) and great loss in quality of life. The global pain management drugs and devices market was estimated to be worth $38 billion in 2015 and reach $51 billion in 2022 at a CAGR of 4%. Founded in 2013, Sea4Us has received over 525.000€ in Portuguese and European Research Grants, raised 10.000€ with crowdfunding, and 250.000€ in venture capital, supporting a team of 13 professionals and is focused on developing the Sea4Pain roll-to-market of innovative treatments.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SEA4PAIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SEA4PAIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More  

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More